The Key Opinion Leader advisory board is in place, the sales team is in place, 4 surgeons from different leading cardiac hospitals are now authorised to use CardioCel...... Beginning with Singapore Asia is set to become a big revenue earner for the company over the next decade. Congratulations to management for securing yet another important milestone.
Ann: CardioCel gains special access in Singapore, page-5
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.75 |
Change
-0.250(1.39%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $17.75 | $43.35K | 2.423K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 303 | $17.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.91 | 32 | 2 |
View Market Depth
| Last trade - 12.33pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |